This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cyclical Sectors Gain Momentum in Early 2021: 7 Top Picks
by Nalak Das
We have narrowed down our search to seven cyclical stocks that have popped more than 10% year to date and still have upside left for 2021. These are: DEN, CFG, GS, AXON, EMN, CAT and SMG.
Will Eastman Chemical (EMN) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Eastman Chemical (EMN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
EMN or AIQUY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EMN vs. AIQUY: Which Stock Is the Better Value Option?
Why Eastman Chemical (EMN) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Chemical Stock Earnings to Watch on Feb 9: DD, FMC & More
by Anindya Barman
A rebound in demand in major markets and benefits of self-help actions are likely to have aided the performance of chemical companies in Q4. Let's see how DD, FMC, GRA and AVNT are poised ahead of their earnings releases.
This is Why Eastman Chemical (EMN) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
EMN or AIQUY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EMN vs. AIQUY: Which Stock Is the Better Value Option?
Eastman Chemical (EMN) Tops Earnings & Sales Estimates in Q4
by Zacks Equity Research
Eastman Chemical (EMN) benefits from its innovation-driven growth model and cost-management actions in the fourth quarter.
Eastman Chemical (EMN) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 10.46% and 2.05%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Eastman Chemical (EMN) Might Surprise This Earnings Season
by Zacks Equity Research
Eastman Chemical (EMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
LyondellBasell (LYB) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
LyondellBasell's (LYB) Q4 performance is likely to have benefited from higher demand for polyethylene.
Chemical Stock Q4 Earnings Slated on Jan 28: DOW, EMN & More
by Anindya Barman
Benefits of strategic measures and an upturn in demand in major markets are likely to have aided the performance of chemical companies in Q4. Let's see how DOW, CE, EMN and OLN are poised ahead of their earnings releases.
5 Chemical Stocks Likely to Outshine Q4 Earnings Estimates
by Anindya Barman
Improved end-market demand and benefits of self-help actions are likely to reflect on the performance of LYB, OLN, OEC, EMN and DOW in Q4.
What's in Store for Sherwin-Williams (SHW) in Q4 Earnings?
by Zacks Equity Research
Sherwin-Williams' (SHW) fourth-quarter results are likely to reflect continued strong demand for architectural coatings in North America.
Nucor (NUE) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Nucor's (NUE) Q4 results are likely to have gained from strong demand in major markets and higher steel prices.
Dow (DOW) Gears Up for Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Dow (DOW) is likely to have gained from cost synergy savings and productivity actions in the fourth quarter.
Celanese (CE) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese's (CE) Q4 performance is likely to have benefited from productivity actions, investments in high-return organic projects and strategic acquisitions.
What's in Store for Eastman Chemical (EMN) in Q4 Earnings?
by Zacks Equity Research
Benefits of cost-management actions are expected to get reflected on Eastman Chemical's (EMN) fourth-quarter results.
Eastman Chemical (EMN) Stock Rallies 40% in 6 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) benefits from demand recovery in its markets, innovation and cost actions.
Here's Why You Should Buy Eastman Chemical (EMN) Right Now
by Zacks Equity Research
Eastman Chemical (EMN) benefits from innovation, cost-management actions, acquisitions and improved demand across its end markets.
4 Diversified Chemical Stocks Set to Ride the Industry's Upturn
by Anindya Barman
An uptick in demand in key end-markets from pandemic-led shocks should enable the Zacks Chemicals Diversified industry to thrive. PPG, CC, CBT and KOP are set to gain from improving industry fundamentals and strategic actions.
Should Value Investors Choose Eastman Chemical (EMN) Stock?
by Zacks Equity Research
Let's see if The Eastman Chemical (EMN) stock is a good choice for value-oriented investors right now from multiple angles.
Eastman Chemical (EMN) Stock Up 27% in 3 Months: Here's Why
by Zacks Equity Research
Eastman Chemical (EMN) benefits from its innovation-driven growth model, cost-management actions and acquisitions.
Eastman Chemical (EMN) Announces Hike in Quarterly Dividend
by Zacks Equity Research
Eastman Chemical (EMN) Board increases quarterly dividend for 11th consecutive year.
Eastman (EMN) to Expand Tertiary Amines Capacity at Ghent Plant
by Zacks Equity Research
Eastman (EMN) to increase its capacity to produce tertiary amines at its Ghent facility by the end of 2021.